Alaska Controlled Substances Advisory Committee White Paper

First Page		Document Content
Date: 2016-03-07 15:17:14 Psychiatric diagnosis Morphinans Pharmaceuticals policy RTT Clinical pharmacology Prescription monitoring program Medical prescription Prescription drug Naloxone Drug Enforcement Administration Heroin Opioid		Alaska Controlled Substances Advisory Committee White Paper Add to Reading List Source URL: www.law.alaska.gov Download Document from Source Website File Size: 432,13 KB Share Document on Facebook

	Prescription Drug Monitoring Program Facts, Figures, and Trends 2nd Quarter 2017 North Dakota Board of Pharmacy Kathy Zahn, RPh Tech, CPhT, Program Administrator 1906 E. Broadway Ave DocID: 1vfFG - View Document
	COMBATING OPIATE ABUSE ACROSS THE DRUG SUPPLY CHAIN Stronger Regulation of Drug Wholesalers Provides Better Tools to Find and Stop Illegal Distribution of Prescription Drugs in Ohio Ohio has helped lead the way in the na DocID: 1v9jf - View Document
	REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax: Address: Fax Number: Envision Rx Options DocID: 1v86s - View Document
	Substance Use Disorder Treatment and Breast Cancer Imaging Cost-Sharing Rider {Drafting Note: Use this rider for plans that provide large group coverage that does not include prescription drug coverage.} T DocID: 1v0LJ - View Document
	Bill 3824: Prescription drug monitoring program DocID: 1uVvP - View Document